Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-06-09 Sale |
2025-06-11 5:05 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
4,904 | $0.622 | $3,050 | 405,982 (Direct) |
View |
2025-06-09 Sale |
2025-06-11 5:05 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
552 | $0.622 | $343 | 250,141 (Direct) |
View |
2025-06-09 Sale |
2025-06-11 5:05 pm |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
475 | $0.622 | $295 | 1,681,783 (Direct) |
View |
2025-06-09 Sale |
2025-06-11 5:04 pm |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
526 | $0.622 | $327 | 484,820 (Indirect Direct) |
View |
2025-05-16 Sale |
2025-05-20 4:19 pm |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
29,552 | $0.546 | $16,135 | 1,682,258 (Direct) |
View |
2025-05-05 Sale |
2025-05-07 4:38 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
1,024 | $0.55 | $563 | 250,693 (Direct) |
View |
2025-05-05 Sale |
2025-05-07 4:38 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
295 | $0.55 | $162 | 410,886 (Direct) |
View |
2025-03-10 Sale |
2025-03-12 7:30 pm |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
2,235 | $0.615 | $1,375 | 2,233,310 (Direct) |
View |
2025-03-10 Sale |
2025-03-12 7:28 pm |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
2,360 | $0.615 | $1,451 | 605,346 (Indirect Direct) |
View |
2025-03-10 Sale |
2025-03-12 7:27 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
2,359 | $0.615 | $1,451 | 371,717 (Direct) |
View |
2025-03-10 Sale |
2025-03-12 7:26 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
1,240 | $0.615 | $763 | 506,806 (Direct) |
View |
2025-02-18 Sale |
2025-02-20 4:00 pm |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
34,712 | $0.783 | $27,179 | 1,192,545 (Direct) |
View |
2025-02-03 Sale |
2025-02-05 5:31 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
1,054 | $0.78 | $822 | 134,076 (Direct) |
View |
2025-02-03 Sale |
2025-02-05 5:30 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
351 | $0.78 | $274 | 316,796 (Direct) |
View |
2024-11-04 Sale |
2024-11-05 4:59 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
1,033 | $1.227 | $1,267 | 135,130 (Direct) |
View |
2024-11-04 Sale |
2024-11-05 4:59 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
283 | $1.227 | $347 | 317,147 (Direct) |
View |
2024-09-12 Purchase |
2024-09-16 4:18 pm |
Century Therapeutics Inc. | IPSC | Quimi Daphne Director |
5,000 | $1.5314 | $7,657 | 5,000 (Direct) |
View |
2024-08-05 Sale |
2024-08-07 4:06 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
1,073 | $1.827 | $1,960 | 136,163 (Direct) |
View |
2024-08-05 Sale |
2024-08-07 4:06 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
289 | $1.827 | $528 | 334,041 (Direct) |
View |
2024-07-26 Sale |
2024-07-31 09:08 am |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
586 | $2.5 | $1,465 | 367,706 (Indirect Direct) |
View |
2024-07-23 Sale |
2024-07-25 5:04 pm |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
1,800 | $2.5164 | $4,529 | 368,292 (Indirect Direct) |
View |
2024-06-20 Sale |
2024-06-24 4:49 pm |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
5,000 | $2.8357 | $14,179 | 370,092 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-06-12 Option Award |
2025-06-16 6:26 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-06-12 Option Award |
2025-06-16 6:26 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-06-12 Option Award |
2025-06-16 6:25 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | Riva Alessandro Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-06-12 Option Award |
2025-06-16 6:25 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-06-12 Option Award |
2025-06-16 6:24 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | Quimi Daphne Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-06-12 Option Award |
2025-06-16 6:23 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-06-12 Option Award |
2025-06-16 6:23 pm |
N/A 2035-06-12 |
Century Therapeutics Inc. | IPSC | Walbert Timothy P Director |
44,000 | $0 | 44,000 (Direct) |
View |
2025-03-11 Option Award |
2025-03-12 7:31 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Conn Morgan Chief Finanical Officer |
19,500 | $0 | 99,148 (Direct) |
View |
2025-03-11 Option Award |
2025-03-12 7:31 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer |
19,500 | $0 | 260,503 (Direct) |
View |
2025-03-11 Option Award |
2025-03-12 7:30 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
521,500 | $0 | 2,233,310 (Direct) |
View |
2025-03-11 Option Award |
2025-03-12 7:28 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
120,000 | $0 | 605,346 (Direct) |
View |
2025-03-11 Option Award |
2025-03-12 7:27 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
120,000 | $0 | 371,717 (Direct) |
View |
2025-03-11 Option Award |
2025-03-12 7:26 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
95,625 | $0 | 506,806 (Direct) |
View |
2024-12-04 Tax Withholding |
2024-12-06 4:57 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
243,447 | $1.44 | 1,227,257 (Direct) |
View |
2024-11-01 Tax Withholding |
2024-11-05 4:59 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
16,611 | $1.26 | 317,147 (Direct) |
View |
2024-10-14 Option Award |
2024-10-16 4:58 pm |
N/A 2034-10-14 |
Century Therapeutics Inc. | IPSC | Conn Morgan Chief Finanical Officer |
421,038 | $0 | 421,038 (Direct) |
View |
2024-10-01 Option Award |
2024-10-03 6:04 pm |
N/A 2034-10-01 |
Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer |
520,626 | $0 | 667,753 (Direct) |
View |
Ownership |
2024-10-03 6:04 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer |
0 | $0 | 147,127 (Direct) |
View |
2024-06-20 Option Award |
2024-06-21 4:51 pm |
N/A 2034-06-20 |
Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director |
44,000 | $0 | 44,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-21 4:51 pm |
N/A 2034-06-20 |
Century Therapeutics Inc. | IPSC | Walbert Timothy P Director |
44,000 | $0 | 44,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-21 4:50 pm |
N/A 2034-06-20 |
Century Therapeutics Inc. | IPSC | Quimi Daphne Director |
44,000 | $0 | 44,000 (Direct) |
View |
2024-06-20 Option Award |
2024-06-21 4:50 pm |
N/A 2034-06-20 |
Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director |
44,000 | $0 | 44,000 (Direct) |
View |